Medical cannabis and the patient experience in the UK
These preliminary findings suggest that the short-term use of cannabis during chemotherapy treatment improved disease-related symptoms and did not affect cognitive skills in patients with cancer.
A prospective evaluation of possible influences on patients with cancer during chemotherapy
These preliminary findings suggest that the short-term use of cannabis during chemotherapy treatment improved disease-related symptoms and did not affect cognitive skills in patients with cancer.
The level of evidence of medical marijuana use for treating disabilities
Chronic pain is the leading cause of disability and is the most common cause of long-term disability
Clinical endocannabinoid deficiency (CECD) revisited
A review of the literature indicates that significant progress has been made since Dr. Ethan B. Russo’s landmark paper, just ten years ago
Patterns of medicinal cannabis use, strain analysis, and substitution effect
Abstract BACKGROUND: Medicinal cannabis registries typically report pain as the most common reason for use. It would be clinically useful to identify patterns of cannabis treatment in migraine and headache, as compared to arthritis and chronic pain, and to analyze preferred cannabis strains, biochemical profiles, and prescription medication substitutions with cannabis. METHODS: Via electronic survey in medicinal cannabis patients with headache, arthritis, and chronic pain, demographics and…
Depression and anxiety among chronic pain patients receiving prescription opioids and medical marijuana
Abstract BACKGROUND: High rates of depression and anxiety have been consistently reported among patients suffering from chronic pain. Prescription opioids are one of the most common modalities for pharmacological treatment of pain, however in recent years medical marijuana(MM) has been increasingly used for pain control in the US and in several countries worldwide. The aim of…
Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases
The target dose for relieving pain in patients with malignant diseases is most likely about 10 actuations per day
The Consumption of Cannabis by Fibromyalgia Patients in Israel
Fibromyalgia might have a tremendous physical and psychological impact on patients and may lead to disability.
Prevalence and correlates of sleep-related problems in adults
Abstract PURPOSE: To examine the prevalence and correlates of sleep problems in a sample of medical cannabis patients. PROCEDURES: Adults ages 21 and older (N=801,M age=45.8) who were seeking medical cannabis certification (either for the first time or as a renewal) for chronic pain at medical cannabis clinics in southern Michigan completed baseline measures of cannabis use, sleep, pain, and other related constructs.…
Joints for joints: cannabinoids in the treatment of rheumatoid arthritis
Abstract PURPOSE OF REVIEW: An increasing number of patients with rheumatoid arthritis (RA) are using cannabis to treat their symptoms, although systematic studies regarding efficacy in RA are lacking. Within this review we will give an overview on the overall effects of cannabinoids in inflammation and why they might be useful in the treatment of RA. RECENT…